Community treatment intervention with ivermectin to reduce the prevalence of scabies and strongyloides

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Scabies and strongyloides are endemic in many remote East Arnhem Aboriginal communities. To reduce the prevalence of these parasitic infections a community treatment intervention will be undertaken using the drug Ivermectin. The introduction of this innovative drug treatment regime for both scabies and strongyloides will be a first in Australia.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: Postgraduate Scholarships

Funding Amount: $109,046.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Antiparasitic | Burden of disease | Clinical trial | Community intervention study | Indigenous health